Inotek Pharmaceuticals Corporation To Present At Glaucoma 360 New Horizons Forum

LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corporation (NASDAQ: ITEK), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for ocular diseases, today announced that Cadmus Rich, M.D., Vice President, Medical Affairs and Clinical Development of Inotek, will present at Glaucoma 360: New Horizons Forum. The Forum is part of the Glaucoma Research Foundation’s 5th Annual Glaucoma 360 meeting on Friday, January 29, 2016 at the Palace Hotel in San Francisco, California.